Search ViroGates A/S Products
ViroGates is an international Biotechnology company headquartered in Denmark. Known for its developed product line called suPARnostic®, ViroGates aims to make a difference in health management by providing information that will empower clinicians to save lives, reduce healthcare cost and provide patients with the treatment or lifestyle changes they need. ViroGates aims to make the suPAR test widely available in commercial environments and seeks to have it implemented and used for clinical decision making.
suPARnostic® is developed to measure the amount of suPAR protein in human blood. A high suPARnostic® level indicates an increased risk of negative outcomes, and should result in appropriate treatment to lower this level. This technology can improve how low risk patients are managed, and as a result can help doctors to prioritize selection of treatment and monitoring of patients. Ultimately, this can lead to a better and more efficient allocation of healthcare resources.
For further information on suPAR PubMed Publications, see the following links:
Click here for suPAR PubMed Publications and links – Organ and Disease grouped
Click here for suPAR Pub Med Publications and Links – listed by publication year
Still Need More Help?
If you have sales questions relative to particular products or to your line of research,
please contact the CEDARLANE® sales department and have all of your questions answered
in a timely and professional manner.